We are looking for young people aged 2 to 17 years to join a Crohn’s disease study to help us discover more about treating Crohn’s. If you are looking for a potential new treatment option for Crohn’s or moderate to severe ulcerative colitis (including associated symptoms such as cramping, reduced appetite, cramps, weight loss and/or liver disease), consider one of our IBD studies. All eligible participants will receive no-cost study-related care and study medication. Your young people aged 2 to 17 years may be eligible to take part.
Your child may be eligible to take part in the IBD studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Act now.
